Search

everythinglearnresearchcommunity

for

Search:↓

A substance called Compound 2g can strongly block STS (a hormone-related enzyme) without affecting estrogen levels, making it potentially good for treating breast cancer.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

Topical finasteride may help treat facial hirsutism in women.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

A new compound may treat benign prostatic hyperplasia better than finasteride.

Finasteride may help reduce male hair loss and excessive hair growth by lowering DHT levels.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Finasteride has a higher risk of reproductive side effects than minoxidil.

The combination therapy effectively treats infertility in PCOS without major side effects.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

Finasteride effectively reduces DHT and E2 levels, helping with prostate enlargement.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

Some drugs can reduce male semen quality.

Topical finasteride works faster and better than 17α-estradiol for postmenopausal hair loss.

Genetic differences affect breast cancer treatment success with tamoxifen in South African patients.

Dutasteride is linked to a higher chance of sexual dysfunction, especially in younger males and the elderly.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Stopping the drug usually helps, but tamoxifen or surgery may be needed if symptoms persist.

5-alpha reductase inhibitors are generally safe but can cause sexual side effects and require patient education on risks.

Finasteride, a drug, can block the seizure-preventing effects of a hormone called progesterone in mice.

Tofacitinib taken by mouth helps treat hair loss in children.